Marker Therapeutics, Inc. (MRKR) Company Profile & Overview - Stock Analysis
MasterControl, Inc. - Marker Therapeutics is the first during the COVID-19 pandemic to receive emergency use authorization for a blood purification system. We're hopeful for the difference this will make for at-risk
Bullish insiders bet US$1.3m on Marker Therapeutics, Inc. (NASDAQ:MRKR)
Marker Therapeutics' (MRKR) 52 Week High at $1.43 & Low at $0.26
Marker Therapeutics, Inc. - Pioneering a Multi-Antigen Approach
Marker Therapeutics, Inc. Common Stock (MRKR) Stock Price, Quote, News & History | Nasdaq
Marker Therapeutics, Inc. (NASD:MRKR) Seasonal Chart | Equity Clock